Modulation of C2 and C3 gene expression of human peripheral blood monocytes by interleukin 1β, interferon γ, tumor necrosis factor α and lipopolysaccharideSHIMIZU, H; SAKANO, T; FUJIE, A et al.Experientia. 1992, Vol 48, Num 11-12, pp 1148-1150, issn 0014-4754Article

INHERITED STRUCTURAL POLYMORPHISM IN HUMAN C₂: EVIDENCE FOR GENETIC LINKAGE BETWEEN C₂ AND BF.ALPER CA.1976; J. EXPER. MED.; U.S.A.; DA. 1976; VOL. 144; NO 4; PP. 1111-1115; BIBL. 1 P. 1/2Article

Polymorphisme du composé C2 et du facteur B du complément chez l'homme = Human complement C2 and factor B polymorphismJahn, Isabelle; Hauptmann, G.1994, 237 p.Thesis

The mechanism of action of decay-accelerating factor (DAF) DAF inhibits the assembly of C3 convertases by dissociating C2a and BbFUJITA, T; INOUE, T; OGAWA, K et al.The Journal of experimental medicine. 1987, Vol 166, Num 5, pp 1221-1228, issn 0022-1007Article

C₃ NEPHRITIC FACTOR STABILIZATION OF THE CLASSIC C₃ CONVERTASE A ROLE FOR C₂ IN C₃ NEPHRITIC FACTOR ACTIVITYMCEAN RH; NILSON SH.1979; PROC. SOC. EXPER. BIOL. MED.; USA; DA. 1979; VOL. 161; NO 3; PP. 358-363; BIBL. 20 REF.Article

Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditisPARKES, A. B; DARKE, C; OTHMAN, S et al.European journal of endocrinology. 1996, Vol 134, Num 4, pp 449-453, issn 0804-4643Article

Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish populationREGUEIRO, J. R; ARNAIZ-VILLENA, A.Tissue antigens. 1988, Vol 31, Num 1, pp 14-25, issn 0001-2815Article

Synergism between γ interferon and lipopolysaccharide for synthesis of factor B, but not C2, in human fibroblastsKATZ, Y; COLE, F. S; STRUNK, R. C et al.The Journal of experimental medicine. 1988, Vol 167, Num 1, pp 1-14, issn 0022-1007Article

Dual effects of TNF on synthesis of Complement components by a gastric cancer-derived cell line, KATO-IIIKITANO, E; KITAMURA, H.International archives of allergy and immunology. 1999, Vol 119, Num 1, pp 54-59, issn 1018-2438Article

Genetic deficiencies of complementLOKKI, M.-L; COLTEN, H. R.Annals of medicine (Helsinki). 1995, Vol 27, Num 4, pp 451-459, issn 0785-3890Article

Enhanced resolution of the SstI polymorphic variants of the C2 locus: description of a new size classRATANACHAIYAVONG, S; CAMPBELL, R. D; MCGREGOR, A. M et al.Human immunology. 1989, Vol 26, Num 4, pp 310-320, issn 0198-8859Article

Identification of a human non-interferon lymphokine activating monocyte complement biosynthesisDROUET, C; REBOUL, A; COLOMB, M et al.Biochemical journal (London. 1906). 1989, Vol 263, Num 1, pp 157-164, issn 0006-2936, 8 p.Article

Caractérisation structurale et fonctionnelle d'une lymphokine activatrice du monocyte humainDrouet, Christian; Colomb, Maurice.1988, 167 p.Thesis

Primary structure of human complement component C2: homology to two unrelated protein familiesBENTLEY, D. R.Biochemical journal (London. 1906). 1986, Vol 239, Num 2, pp 339-345, issn 0006-2936Article

THE CHROMOSOMAL ORDER OF GENES CONTROLLING THE MAJOR HISTOCOMPATIBILITY COMPLEX, PROPERDIN FACTOR B AND DEFICIENCY OF THE SECOND COMPONENT OF COMPLEMENT.RAUM D; GLASS D; CARPENTER CB et al.1976; J. CLIN. INVEST.; U.S.A.; DA. 1976; VOL. 58; NO 5; PP. 1240-1248; BIBL. 1 P. 1/2Article

LIMITED PROTEOLYSIS OF COMPLEMENT COMPONENTS C2 AND FACTOR B. STRUCTURAL ANALOGY AND LIMITED SEQUENCE HOMOLOGYKERR MA.1979; BIOCHEM. J.; GBR; DA. 1979; VOL. 183; NO 3; PP. 615-622; BIBL. 28 REF.Article

RECURRENT SEPTICEMIA ASSOCIATED WITH CONGENITAL DEFICIENCY OF C2 AND PARTIAL DEFICIENCY OF FACTOR B AND THE ALTERNATIVE COMPLEMENT PATHWAYS.NEWMAN SL; VOGLER LB; FEIGIN RD et al.1978; NEW ENGL. J. MED.; USA; DA. 1978; VOL. 299; NO 6; PP. 290-292; BIBL. 21 REF.Article

STRUCTURE AND ACTIVATION OF THE EARLY COMPONENTS OF COMPLEMENT.PORTER RR.1977; FEDER. PROC.; U.S.A.; DA. 1977; VOL. 36; NO 9; PP. 2191-2196; BIBL. 48 REF.Article

THE SERINE PROTEASE NATURE OF THE C3 AND C5 CONVERTASES OF THE CLASSICAL AND ALTERNATIVE COMPLEMENT PATHWAYS.MEDICUS RG; GOETZE O; MULLER EBERHARD HJ et al.1976; SCAND. J. IMMUNOL.; NORWAY; DA. 1976; VOL. 5; NO 9; PP. 1049-1055; BIBL. 1 P. 1/2Article

GENETIC POLYMORPHISM OF HUMAN COMPLEMENT PROTEINSHAUPTMANN G.1979; REV. FR. TRANSFUS. IMMUNO. HEMATOL.; FRA; DA. 1979; VOL. 22; NO 5; PP. 587-614; ABS. FRE; BIBL. 107 REF.Article

Regulation of class III major histocompatibility complex gene products by interleukin-1PERLMUTTER, D. H; GOLDBERGER, G; DINARELLO, C. A et al.Science (Washington, D.C.). 1986, Vol 232, Num 4752, pp 850-852, issn 0036-8075Article

BREVET 2.320.924 (A1) (76 24532). - 11 AOUT 1976. PROCEDE DE CONVERSION D'HYDROCARBURES POUR LA PRODUCTION NOTAMMENT D'UN PRODUIT RENFERMANT DES HYDROCARBURES A DEUX ATOMES DE CARBONE.sdPatent

PARTICIPATION OF AN EARLY COMPONENT OF COMPLEMENT AND HAGEMAN FACTOR IN C3 DESTRUCTION BY ZYMOSANGIGLI I; KOETHE S; AUSTEN KF et al.1975; CLIN. IMMUNOL. IMMUNOPATHOL.; U.S.A.; DA. 1975; VOL. 4; NO 2; PP. 189-198; BIBL. 27 REF.Article

MEASUREMENT OF C₂ AND C₃ RECOVERY AND TOTAL FRACTION CONDENSED FOR A SIMULATED NATURAL GAS, PROPOSED MEASUREMENT PROGRAM = MESURE DE LA RECUPERATION DE C₂ ET C₃ ET DE LA FRACTION CONDENSEE TOTALE POUR UN GAZ NATUREL SIMULE. PROGRAMME DE MESURE PROPOSEWILSON GM.sdIN: GAS PROCESS. ASSOC. ANNU. CONV. TECH. PAP.; DENVER, COLO.; 1974; S.L.; DA. S.D.; PP. 8-11Conference Paper

FIXATIONS QUANTITATIVES COMPAREES DU COMPLEMENT TOTAL ET DE SES QUATRE PREMIERS COMPOSANTS (C1, C4, C2 ET C3) AU COURS DES REACTIONS ANTIGENE-ANTICORPS IN VITROLEROY C; PELTIER AP.1973; ANN. IMMUNOL.; FR.; DA. 1973; VOL. 124; NO 1; PP. 87-96; ABS. ANGL.; BIBL. 8 REF.Serial Issue